ROC curves for HRI-S and HRI-R versus hepatic steatosis defined by abdominal ultrasound.

<p>ROC curves for HRI-S and HRI-R versus hepatic steatosis defined by abdominal ultrasound.</p

AUCs and cutoff values of ROC curves for prediction of hepatic steatosis and prediction of central obesity by fetuin A, chemerin levels, WC, WHR and WHtR.

<p>Note: Values expressed as AUC ± SE (95% confidence interval) and cutoff level, sensitivity/specificity.</p><p>Abbreviations: AUC, area under curve; ROC, receiver operating characteristic; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio.</p>*<p>AUC of chemerin was greater than that of fetuin A (P<i> = </i>0.02), which was estimated by means of nonparametric statistical analysis (DeLong test).</p

Basic characteristics of all participants.

<p>Abbreviations: DM, diabetic mellitus; HD, hemodialysis; nPCR, normalized protein catabolic rate; BMI, body mass index; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio; Ca, calcium; P, phosphorus; CaxP, calcium phosphate product; iPTH, intact parathyroid hormone; T-CHO, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein; HDL-C, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance hs-CRP, highly sensitive C-reactive protein.</p><p><i>Note:</i> Conversion factors for units: hemoglobin in g/dL to g/L, ×10; serum calcium in mg/dL to mmol/L, ×0.2495; serum phosphate in mg/dL to mmol/L, ×0.3229; serum LDL-C in mg/dL to mmol/L, ×0.02586; serum TG in mg/dL to mmol/L, ×0.01129; serum albumin in g/dL to g/L, ×10. No conversion necessary for platelet counts in ×10³/uL and ×10⁹/L; serum iPTH in pg/mL and ng/L; serum potassium in mEq/L and mmol/L.</p

Relationships of serum fetuin A levels with serum chemerin levels in univariate model (regression line and 95% CI).

<p>Relationships of serum fetuin A levels with serum chemerin levels in univariate model (regression line and 95% CI).</p

ORs for fetuin A, chemerin levels and WC to hepatic steatosis and central obesity by logistic regression analysis.

*<p>Multivariate analysis included fetuin A, chemerin levels, WC, age, hemodialysis vintage, gender, diabetes mellitus, hs-CRP, albumin, Kt/V_urea and CaXP levels as covariates.</p>#<p>Multivariate analysis included fetuin A, chemerin levels, age, gender, diabetes mellitus, albumin and Kt/V_urea as covariates.</p><p>Abbreviations: ORs: odds ratio; WC: waist circumference.</p

Ultrasound image shows selected regions of interest (ROI) (<i>circles</i>).

<p>Ultrasound image shows selected regions of interest (ROI) (<i>circles</i>).</p

Relationships of serum fetuin A levels with hepato-renal index (HRI-S).

<p>(a) and with HRI-R (b) in univariate model (regression line and 95% CI).</p

Additional file 1: of Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease

Table S1. Correlations between HCMV-specific IgG titer with levels of immune cells among healthy individuals. Table S2. Associations between log-transformed HCMV-specific IgG level with coronary artery disease and cardiovascular disease. (DOCX 26 kb

Linear regression analysis of predictors associated with the change score of pruritus intensity.

<p>NOTE. Each participant’s change score of pruritus intensity = follow-up VAS score of pruritus intensity – baseline VAS score of pruritus intensity. Similarly, each participant’s change score of a covariate = follow-up data of a covariate – baseline data of a covariate.</p><p>Abbreviations: AST, aspartate transaminase; VAS, visual analog scale.</p>*<p>Ca×P = Product of albumin-adjusted serum calcium (Ca) and serum phosphorus (P).</p>1<p>Model considered only the covariates measured at baseline (gender, Kt/V, use of high-flux dialyzer, pruritus intensity, hematocrit, creatinine, uric acid, fasting glucose, total bilirubin, Ca×P). <i>R</i>² = 0.736.</p>2<p>Model considered both the covariates measured at baseline (Kt/V, pruritus intensity, AST, Ca×P) and the change scores of the covariates (uric acid, fasting glucose, AST). <i>R</i>² = 0.752.</p

Demographic and clinical characteristics of participants at baseline.

<p>NOTE. Data are expressed as mean ± S.D. or number (percentage).</p